EUVIMEDOpdag EUVIMED
KohortenstudieOpen access · CC BY 4.0

Risk factors for severe hearing loss in Susac syndrome: A national cohort study

Marion Peyre, Arthur Mageau, Marie-Cécile Henry Feugeas, Serge Doan, Caroline Halimi, Isabelle Klein, Tiphaine Goulenok, Chrystelle François, Marie-Paule Chauveheid, Thomas Papo, Karim Sacré iD, French Susac Study Group

European Journal of Neurology · 2024

DOI: 10.1111/ene.16211 ↗

At a glance

Kohortenstudie in European Journal of Neurology, 2024. Written by Marion Peyre and 11 co-authors. Institution: Department of Internal Medecine, Hospital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France. Major MEDLINE topics: Susac Syndrome, Hearing Loss. Cited 9 times so far (Crossref); 13 references. The full text is freely available (open access, CC BY 4.0). Funded by: French CRC, French national PHRC.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Nonreversible hearing loss (HL) is the main sequelae of Susac syndrome (SuS). We aimed to identify risk factors for HL in SuS.

Methods

The CARESS study is a prospective national cohort study that started in December 2011, including all consecutive patients with SuS referred to the French reference center. The CARESS study was designed with a follow‐up including fundoscopy, audiometry, and brain magnetic resonance imaging at 1, 3, 6, and 12 months after diagnosis and then annually for 5 years. The primary outcome was the occurrence at last follow‐up of severe HL defined as the loss of 70 dB in at least one ear on audiometry or the need for hearing aids.

Results

Thirty‐six patients (female 66.7%, median age 37.5 [range 24.5–42.5] years) included in the clinical study were analyzed for the primary outcome. Thirty‐three patients (91.7%) had cochleovestibular involvement at SuS diagnosis including HL >20 dB in at least one ear in 25 cases. At diagnosis, 32 (88.9%), 11 (30.6%), and 7 (19.4%) patients had received steroids, intravenous immunoglobulin, and/or immunosuppressive (IS) drugs, respectively. After a median follow‐up of 51.8 [range 29.2–77.6] months, 19 patients (52.8%) experienced severe HL that occurred a median of 13 [range 1.5–29.5] months after diagnosis. Multivariable analysis showed that the odds of severe HL were lower in patients who received IS drugs at diagnosis (OR 0.15, 95% CI 0.01–1.07, p = 0.058).

Conclusions

Severe HL in SuS is associated with the absence of IS drugs given at diagnosis. Our findings support the systematic use of IS drugs in SuS.

Subjects

MeSH terms (MEDLINE)

Susac SyndromeHearing LossHumansFemaleYoung AdultAdultCohort StudiesProspective StudiesImmunosuppressive AgentsRisk Factors

Author keywords

Susac syndromehearing lossrisk factors

Substances

Immunosuppressive Agents

Authors and institutions

  • Department of Internal Medecine, Hospital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.
  • Department of Radiology, Hospital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.
  • Department of Ophthalmology, Hospital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.
  • Department of Otolaryngology - Head and Neck Surgery, Hospital Bichat-Claude Bernard, Assistance Publique Hôpitaux de Paris, Université Paris Cité, Paris, France.
  • Department of Radiology, Clinique Alleray-Labrouste, Paris, France.
  • Centre de Recherche sur l'Inflammation, INSERM UMR1149, CNRS ERL8252, Faculté de Médecine site Bichat, Laboratoire d'Excellence Inflamex, Paris, France.

ORCID profiles: Karim Sacré

Funding

  • French CRC
  • French national PHRC

Cite

APA

Peyre, M., Mageau, A., Henry Feugeas, M. C., Doan, S., Halimi, C., Klein, I., Goulenok, T., François, C., Chauveheid, M. P., Papo, T., Sacré, K., & French Susac Study Group (2024). Risk factors for severe hearing loss in Susac syndrome: A national cohort study. European Journal of Neurology. https://doi.org/10.1111/ene.16211

Vancouver

Peyre M, Mageau A, Henry Feugeas MC, Doan S, Halimi C, Klein I, et al. Risk factors for severe hearing loss in Susac syndrome: A national cohort study. European Journal of Neurology. 2024. doi:10.1111/ene.16211

BibTeX
@article{Peyre2024,
  author = {Peyre, Marion and Mageau, Arthur and Henry Feugeas, Marie-Cécile and Doan, Serge and Halimi, Caroline and Klein, Isabelle and Goulenok, Tiphaine and François, Chrystelle and Chauveheid, Marie-Paule and Papo, Thomas and Sacré, Karim and French Susac Study Group, French Susac Study Group},
  title = {Risk factors for severe hearing loss in Susac syndrome: A national cohort study},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16211}
}
Start for free →